The Changing Landscape Of Clinical Monitoring
About the Survey:
Industry Standard Research (ISR) conducted a web-based quantitative survey with 70 participants involved with clinical development clinical monitoring within pharmaceutical, biopharma, biotech, and/or a contract research organizations. This survey was conducted in April/May 2022.
- Respondents reported their companies still use on-site monitoring in a majority of trials, 8 out of 10 on average, but expect this proportion to decrease over the next two years being replaced with central and remote monitoring elements.
- Usage of central monitoring and remote source document review are predicted to increase the most, by 16 and 15 percentage points, respectively, over the next two years.
- Respondents noted reasons for not using some of these clinical monitoring elements including they felt more confident with 100% SDV / SDR or that their organizations were slower to adopt remote and centralized monitoring practices.
VIEW THE INFOGRAPHIC! Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader X
Subscribe to Clinical Leader